These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23265311)

  • 21. Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men.
    Quintana DS; Westlye LT; Smerud KT; Mahmoud RA; Andreassen OA; Djupesland PG
    Horm Behav; 2018 Jun; 102():85-92. PubMed ID: 29750971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin as a moderator of hypnotizability.
    Bryant RA; Hung L; Guastella AJ; Mitchell PB
    Psychoneuroendocrinology; 2012 Jan; 37(1):162-6. PubMed ID: 21652150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast.
    Kundoor V; Dalby RN
    Pharm Res; 2011 Aug; 28(8):1895-904. PubMed ID: 21499839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin increases gaze to the eye region of human faces.
    Guastella AJ; Mitchell PB; Dadds MR
    Biol Psychiatry; 2008 Jan; 63(1):3-5. PubMed ID: 17888410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF and blood oxytocin concentration changes following intranasal delivery in macaque.
    Dal Monte O; Noble PL; Turchi J; Cummins A; Averbeck BB
    PLoS One; 2014; 9(8):e103677. PubMed ID: 25133536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males.
    Alvares GA; Chen NT; Balleine BW; Hickie IB; Guastella AJ
    Psychoneuroendocrinology; 2012 Dec; 37(12):2022-31. PubMed ID: 22613033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus.
    Feng C; Zhang C; Shao X; Liu Q; Qian Y; Feng L; Chen J; Zha Y; Zhang Q; Jiang X
    Int J Pharm; 2012 Feb; 423(2):226-34. PubMed ID: 22193058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
    Bernstein DI; Teper A; Gopalan G; Gates D
    Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oxytocin model of formation of psychotic symptoms and its implications for research on oxytocinergic pathway in schizophrenia].
    Holka-Pokorska J; Jarema M
    Psychiatr Pol; 2014; 48(1):19-33. PubMed ID: 24946432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.
    Okamoto Y; Ishitobi M; Wada Y; Kosaka H
    CNS Neurol Disord Drug Targets; 2016; 15(5):564-77. PubMed ID: 27071789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking Suspension Nasal Spray Drug Deposition Patterns to Pharmacokinetic Profiles: A Proof-of-Concept Study Using Computational Fluid Dynamics.
    Rygg A; Hindle M; Longest PW
    J Pharm Sci; 2016 Jun; 105(6):1995-2004. PubMed ID: 27238495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia.
    Ciancio SG; Hutcheson MC; Ayoub F; Pantera EA; Pantera CT; Garlapo DA; Sobieraj BD; Almubarak SA
    J Dent Res; 2013 Jul; 92(7 Suppl):43S-8S. PubMed ID: 23690356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives.
    Quintana DS; Smerud KT; Andreassen OA; Djupesland PG
    Ther Deliv; 2018 Jul; 9(7):515-525. PubMed ID: 29943688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin.
    Landgraf R
    Exp Clin Endocrinol; 1985 Apr; 85(2):245-8. PubMed ID: 4018162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.
    Guastella AJ; Howard AL; Dadds MR; Mitchell P; Carson DS
    Psychoneuroendocrinology; 2009 Jul; 34(6):917-23. PubMed ID: 19246160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Oxytocin: Myths and Delusions.
    Leng G; Ludwig M
    Biol Psychiatry; 2016 Feb; 79(3):243-50. PubMed ID: 26049207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal oxytocin enhances emotion recognition from dynamic facial expressions and leaves eye-gaze unaffected.
    Lischke A; Berger C; Prehn K; Heinrichs M; Herpertz SC; Domes G
    Psychoneuroendocrinology; 2012 Apr; 37(4):475-81. PubMed ID: 21862223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.